CLINICAL_TRIALS
research
· 2025-12-23
Clinical Trial Update: A Study of GC101 TIL in Advanced Melanoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating GC101 TIL in advanced melanoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Juncell Therapeutics | Conditions: Melanoma | Phase 2 | Status: RECRUITING